APA

Defina M., Ippoliti M., Gozzetti A., Abruzzese E., Castagnetti F., Crupi R., Tiribelli M., Breccia M., Salvucci M., Aprile L., Baratè C., Gozzini A., Rosti G., Lauria F. & Bocchia M. (20130131). Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. : Cancer.

Chicago

Defina Marzia, Ippoliti Micaela, Gozzetti Alessandro, Abruzzese Elisabetta, Castagnetti Fausto, Crupi Rosaria, Tiribelli Mario, Breccia Massimo, Salvucci Marzia, Aprile Lara, Baratè Claudia, Gozzini Antonella, Rosti Gianantonio, Lauria Francesco and Bocchia Monica. 20130131. Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. : Cancer.

Harvard

Defina M., Ippoliti M., Gozzetti A., Abruzzese E., Castagnetti F., Crupi R., Tiribelli M., Breccia M., Salvucci M., Aprile L., Baratè C., Gozzini A., Rosti G., Lauria F. and Bocchia M. (20130131). Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. : Cancer.

MLA

Defina Marzia, Ippoliti Micaela, Gozzetti Alessandro, Abruzzese Elisabetta, Castagnetti Fausto, Crupi Rosaria, Tiribelli Mario, Breccia Massimo, Salvucci Marzia, Aprile Lara, Baratè Claudia, Gozzini Antonella, Rosti Gianantonio, Lauria Francesco and Bocchia Monica. Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. : Cancer. 20130131.